PMID: 16532941Mar 15, 2006Paper

Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies

Medical Physics
Rebecca M HowellGary D Fullerton

Abstract

Effective doses were calculated from the delivery of 6 MV, 15 MV, and 18 MV conventional and intensity-modulated radiation therapy (IMRT) prostate treatment plans. ICRP-60 tissue weighting factors were used for the calculations. Photon doses were measured in phantom for all beam energies. Neutron spectra were measured for 15 MV and 18 MV and ICRP-74 quality conversion factors used to calculate ambient dose equivalents. The ambient dose equivalents were corrected for each tissue using neutron depth dose data from the literature. The depth corrected neutron doses were then used as a measure of the neutron component of the ICRP protection quantity, organ equivalent dose. IMRT resulted in an increased photon dose to many organs. However, the IMRT treatments resulted in an overall decrease in effective dose compared to conventional radiotherapy. This decrease correlates to the ability of an intensity-modulated field to minimize dose to critical normal structures in close proximity to the treatment volume. In a comparison of the three beam energies used for the IMRT treatments, 6 MV resulted in the lowest effective dose, while 18 MV resulted in the highest effective dose. This is attributed to the large neutron contribution for 18 MV...Continue Reading

References

Jun 1, 1997·International Journal of Radiation Oncology, Biology, Physics·D FollowillA Boyer
Jan 1, 1961·Physics in Medicine and Biology·R E ELLIS
Feb 28, 2004·The Journal of Organic Chemistry·Stefano SuperchiCarlo Rosini
Sep 9, 2004·Radiation Protection Dosimetry·F VanhavereL Struelens
Apr 21, 2005·Medical Physics·Rebecca M HowellGary D Fullerton
Jul 2, 2005·International Journal of Radiation Oncology, Biology, Physics·Stephen F KryIsaac I Rosen
Jul 2, 2005·International Journal of Radiation Oncology, Biology, Physics·Stephen F KryIsaac I Rosen

❮ Previous
Next ❯

Citations

Oct 1, 2009·Radiation Protection Dosimetry·Seyyed-Mostafa GhavamiEhsan Mohammadi
Jul 14, 2011·Radiation Protection Dosimetry·S A Martínez-OvalleA M Lallena
Aug 6, 2011·Radiation Protection Dosimetry·V DufekL Novak
Jul 10, 2013·Radiation Oncology·Louise MurrayUNKNOWN BRAPHYQS/PROBATE group of the GEC ESTRO
Dec 13, 2006·Medical Physics·Stephen F KryMohammad Salehpour
Oct 12, 2007·Medical Physics·Stephen F KryMohammad Salehpour
Jun 10, 2008·Physics in Medicine and Biology·X George XuHarald Paganetti
Nov 16, 2010·Physics in Medicine and Biology·Rebecca M HowellDerek Z Yaldo
Jan 15, 2011·Radiation Protection Dosimetry·S A Martínez-OvalleA M Lallena
May 3, 2011·Zeitschrift für medizinische Physik·Henning SalzTilo Wiezorek
Jan 8, 2015·Radiation Protection Dosimetry·Eva BezakLoredana G Marcu
Sep 8, 2009·International Journal of Radiation Oncology, Biology, Physics·Christopher R KingDaniel S Kapp
May 12, 2009·International Journal of Radiation Oncology, Biology, Physics·Daniel R ZwahlenUwe Schneider
May 12, 2009·International Journal of Radiation Oncology, Biology, Physics·Jonas D FontenotWayne D Newhauser
Jul 20, 2007·International Journal of Radiation Oncology, Biology, Physics·Stephen F KryRadhe Mohan
Jul 20, 2007·International Journal of Radiation Oncology, Biology, Physics·Stephen F KryMohammad Salehpour
Feb 6, 2015·Medical Physics·Adam J Uselmann, Bruce R Thomadsen
Apr 23, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Maite R ExpósitoFrancisco Sánchez-Doblado
Mar 17, 2017·Journal of Applied Clinical Medical Physics·Shuxu ZhangHui Yu
Jan 30, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·David B MansurBeth P Maserang
Jan 8, 2016·Dose-response : a Publication of International Hormesis Society·Laetitia Lacoste-CollinMonique Courtade-Saïdi
Mar 25, 2017·Radiation Protection Dosimetry·Masahiko ToyotaSuminori Akiba
May 24, 2018·Physics in Medicine and Biology·H ElazharN Arbor
May 2, 2008·Journal of Applied Clinical Medical Physics·Stephen F KryMohammad Salehpour
Mar 23, 2010·Physics in Medicine and Biology·Stephen F KryRadhe Mohan
Jun 26, 2010·Physics in Medicine and Biology·Ndimofor ChoforBjörn Poppe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved